While the federal government has pushed forward the initial target date of July 1 for legalizing recreational cannabis to Oct. 17, employers will still be busy trying to prepare for all of the issues they’ll have to deal with. Benefits Canada has been covering the issue since Prime Minister Justin Trudeau’s Liberal party first committed to legalizing […]
When it instituted random drug testing last year, the Toronto Transit Commission was eager to ensure its employees knew what it expected of them. To get the message out, the transit authority mailed a handbook last year to the home of every employee and published it online so all workers would be fully aware of […]
A recent study examining the potential savings determined that, based on the uptake of available biosimilars in Organisation for Economic Co-operation and Development countries, Canada could save between eight per cent and 43 per cent. Although Health Canada approved Inflectra, the first biosimilar for Remicade, in 2014 to treat a number of conditions, the drug […]
A red flag goes up for Dan Mead whenever an orthotics customer comes into his clinic asking about getting free shoes. “Clearly, we do see the issue, because patients do come in to our office, just speaking anecdotally . . . and you can tell what they’re looking for,” says Mead, a certified prosthetist and […]
Orphan drugs represent a significant and growing share of new pharmaceutical entrants in Canada, according to a new report from the Patented Medicine Prices Review Board. At 54 per cent of new pharmaceuticals entering the market in 2015 and 42 per cent in 2016, orphan drugs have seen a significant rise from an average of 33 […]
The federal government has announced the appointment of the remaining members of its advisory council on the implementation of national pharmacare. Besides former Ontario health minister Dr. Eric Hoskins, who’s the chair of the advisory council, the members are: Mia Homsy, director general of the Institut du Québec, who will serve as vice-chair of the […]
More than half (52 per cent) of Canadian employers said they’re concerned or very concerned about the implications of legalized marijuana on the workplace, according to a report by the Conference Board of Canada. A third (33 per cent) of respondents said they’re slightly concerned and 15 per cent said they aren’t concerned at all. Among those concerned, 57 per cent cited workplace […]
Advocates for national pharmacare have misdiagnosed the nature of gaps in prescription drug plan coverage in Canada and have proposed the wrong solution, according to a new study by think-tank the Canadian Health Policy Institute. Based on Canada’s 2016 population of almost 36.3 million people, the study found close to 23.2 million had coverage through a private drug plan. The […]
From pharmacare to analytics, plan sponsors heard about the big issues on the horizon for their benefits plans at Benefits Canada‘s Calgary Benefits Summit. Presenters at the May 29 event took the audience through a range of topics, including the implications of marijuana legalization and new developments in health-care delivery. And two years after the […]
By taking the use of data to the next level, employers and insurers can improve their ability to promote better health through benefits plans. That was a key message from Tarick Fadel, director of analytics, research and pricing at Alberta Blue Cross, during a presentation at Benefits Canada‘s Calgary Benefits Summit on May 29. “We […]